{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:09:46Z","timestamp":1790431786140,"version":"4.1.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.biopha.2021.111380","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T01:30:26Z","timestamp":1613439026000},"page":"111380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Therapeutic potential of iron chelators on osteoporosis and their cellular mechanisms"],"prefix":"10.1016","volume":"137","author":[{"given":"Jian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghai","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuguang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biopha.2021.111380_bib1","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s00198-012-1982-1","article-title":"Iron homeostasis in osteoporosis and its clinical implications","volume":"23","author":"Li","year":"2012","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.biopha.2021.111380_bib2","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.freeradbiomed.2013.09.001","article-title":"The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress","volume":"65","author":"Koskenkorva-Frank","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2021.111380_bib3","first-page":"S6","article-title":"Overview of iron metabolism in health and disease","volume":"21","author":"Dev","year":"2017","journal-title":"Hemodial. Int."},{"issue":"2","key":"10.1016\/j.biopha.2021.111380_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12011-019-01867-4","article-title":"The effect of abnormal iron metabolism on osteoporosis","volume":"195","author":"Che","year":"2020","journal-title":"Biol. Trace Elem. Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.111380_bib5","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.3390\/nu7042324","article-title":"Chronic iron deficiency as an emerging risk factor for osteoporosis: a hypothesis","volume":"7","author":"Toxqui","year":"2015","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.biopha.2021.111380_bib6","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1093\/jn\/134.11.3061","article-title":"Iron deficiency negatively affects vertebrae and femurs of rats independently of energy intake and body weight","volume":"134","author":"Medeiros","year":"2004","journal-title":"J. Nutr."},{"issue":"2","key":"10.1016\/j.biopha.2021.111380_bib7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3945\/jn.108.093757","article-title":"Severe iron deficiency decreases both bone formation and bone resorption in rats","volume":"139","author":"Katsumata","year":"2009","journal-title":"J. Nutr."},{"issue":"2","key":"10.1016\/j.biopha.2021.111380_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00394-011-0212-5","article-title":"Severe nutritional iron-deficiency anaemia has a negative effect on some bone turnover biomarkers in rats","volume":"51","author":"D\u00edaz-Castro","year":"2012","journal-title":"Eur. J. Nutr."},{"issue":"6","key":"10.1016\/j.biopha.2021.111380_bib9","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.3168\/jds.2010-4043","article-title":"Goat milk during iron repletion improves bone turnover impaired by severe iron deficiency","volume":"94","author":"D\u00edaz-Castro","year":"2011","journal-title":"J. Dairy Sci."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2021.111380_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s12011-012-9511-9","article-title":"A comparison of the biological activities of human osteoblast hFOB1.19 between iron excess and iron deficiency","volume":"150","author":"Zhao","year":"2012","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.biopha.2021.111380_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fphar.2017.00077","article-title":"Clinical impact and cellular mechanisms of iron overload-associated bone loss","volume":"8","author":"Jeney","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111380_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2018.09.022","article-title":"Iron and redox cycling. Do\u2019s and don\u2019ts","volume":"133","author":"Koppenol","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.111380_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/ijms17010130","article-title":"Iron homeostasis in health and disease","volume":"17","author":"Gozzelino","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl 6","key":"10.1016\/j.biopha.2021.111380_bib14","doi-asserted-by":"crossref","first-page":"1634s","DOI":"10.3945\/ajcn.117.155960","article-title":"Serum ferritin as an indicator of iron status: what do we need to know?","volume":"106","author":"Daru","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.biopha.2021.111380_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3324\/haematol.2019.232124","article-title":"Iron metabolism and iron disorders revisited in the hepcidin era","volume":"105","author":"Camaschella","year":"2020","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.biopha.2021.111380_bib16","first-page":"239","article-title":"A review on iron chelators in treatment of iron overload syndromes","volume":"10","author":"Mobarra","year":"2016","journal-title":"Int. J. Hematol. Oncol. Stem Cell. Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.111380_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/10245332.2016.1199178","article-title":"Labile plasma iron, more practical and more sensitive to iron overload in myelodysplastic syndromes","volume":"22","author":"Gu","year":"2017","journal-title":"Hematology"},{"issue":"5","key":"10.1016\/j.biopha.2021.111380_bib18","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.bbamcr.2015.01.021","article-title":"Cellular iron uptake, trafficking and metabolism: key molecules and mechanisms and their roles in disease","volume":"1853","author":"Lane","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"6641","key":"10.1016\/j.biopha.2021.111380_bib19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/41343","article-title":"Cloning and characterization of a mammalian proton-coupled metal-ion transporter","volume":"388","author":"Gunshin","year":"1997","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biopha.2021.111380_bib20","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0891-5849(02)01006-7","article-title":"The labile iron pool: characterization, measurement, and participation in cellular processes(1)","volume":"33","author":"Kakhlon","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2021.111380_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fphar.2014.00045","article-title":"Labile iron in cells and body fluids: physiology, pathology, and pharmacology","volume":"5","author":"Cabantchik","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2021.111380_bib22","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3324\/haematol.2014.104463","article-title":"Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels","volume":"99","author":"Rossi","year":"2014","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.biopha.2021.111380_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00198-008-0701-4","article-title":"Association between iron overload and osteoporosis in patients with hereditary hemochromatosis","volume":"20","author":"Valenti","year":"2009","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.biopha.2021.111380_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jocd.2019.01.004","article-title":"Bone health in patients with liver diseases","volume":"23","author":"Danford","year":"2019","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.biopha.2021.111380_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.metabol.2017.09.012","article-title":"Bone disease in \u03b2 thalassemia patients: past, present and future perspectives","volume":"80","author":"De Sanctis","year":"2018","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.biopha.2021.111380_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/vox.12201","article-title":"When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia","volume":"108","author":"Taher","year":"2015","journal-title":"Vox Sang."},{"issue":"11","key":"10.1016\/j.biopha.2021.111380_bib27","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/jbmr.1692","article-title":"Iron overload accelerates bone loss in healthy postmenopausal women and middle-aged men: a 3-year retrospective longitudinal study","volume":"27","author":"Kim","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.biopha.2021.111380_bib28","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s00198-013-2363-0","article-title":"The association between higher serum ferritin level and lower bone mineral density is prominent in women >\/=45 years of age (KNHANES 2008-2010)","volume":"24","author":"Kim","year":"2013","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.biopha.2021.111380_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1530\/JOE-14-0657","article-title":"Iron overload increases osteoclastogenesis and aggravates the effects of ovariectomy on bone mass","volume":"226","author":"Xiao","year":"2015","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111380_bib30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s12011-019-01929-7","article-title":"Ionizing radiation exacerbates the bone loss induced by iron overload in mice","volume":"196","author":"Zhang","year":"2019","journal-title":"Biol. Trace Elem. Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.111380_bib31","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bcmd.2015.06.003","article-title":"Experimental animal model to study iron overload and iron chelation and review of other such models","volume":"55","author":"Italia","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"issue":"14","key":"10.1016\/j.biopha.2021.111380_bib32","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1182\/blood-2009-12-260083","article-title":"Bone loss caused by iron overload in a murine model: importance of oxidative stress","volume":"116","author":"Tsay","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.biopha.2021.111380_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207441","article-title":"Iron-enriched diet contributes to early onset of osteoporotic phenotype in a mouse model of hereditary hemochromatosis","volume":"13","author":"Sim\u00e3o","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2021.111380_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00223-013-9817-4","article-title":"Therapeutic effect of deferoxamine on iron overload-induced inhibition of osteogenesis in a zebrafish model","volume":"94","author":"Chen","year":"2014","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.biopha.2021.111380_bib35","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.bbrc.2017.12.172","article-title":"Novel and rapid osteoporosis model established in zebrafish using high iron stress","volume":"496","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.biopha.2021.111380_bib36","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3324\/haematol.2011.049957","article-title":"Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with \u03b2-thalassemia major","volume":"97","author":"Pennell","year":"2012","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.biopha.2021.111380_bib37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1182\/blood-2009-11-250308","article-title":"The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores","volume":"116","author":"Wood","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.biopha.2021.111380_bib38","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/j.gastro.2011.06.065","article-title":"Improvement in liver pathology of patients with \u03b2-thalassemia treated with deferasirox for at least 3 years","volume":"141","author":"Deugnier","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2021.111380_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2018.10.005","article-title":"Lowering iron level protects against bone loss in focally irradiated and contralateral femurs through distinct mechanisms","volume":"120","author":"Zhang","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2021.111380_bib40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.toxlet.2019.06.007","article-title":"Deferoxamine inhibits iron-uptake stimulated osteoclast differentiation by suppressing electron transport chain and MAPKs signaling","volume":"313","author":"Zhang","year":"2019","journal-title":"Toxicol. Lett."},{"issue":"20","key":"10.1016\/j.biopha.2021.111380_bib41","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1182\/blood-2009-05-224188","article-title":"Specific iron chelators determine the route of ferritin degradation","volume":"114","author":"De Domenico","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biopha.2021.111380_bib42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nm.1910","article-title":"Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation","volume":"15","author":"Ishii","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2021.111380_bib43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bone.2016.09.023","article-title":"The regulation of iron metabolism by hepcidin contributes to unloading-induced bone loss","volume":"94","author":"Xu","year":"2017","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.biopha.2021.111380_bib44","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3324\/haematol.2016.144808","article-title":"Wnt5a is a key target for the pro-osteogenic effects of iron chelation on osteoblast progenitors","volume":"101","author":"Baschant","year":"2016","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.biopha.2021.111380_bib45","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.4155\/fmc.09.121","article-title":"Synthetic and natural iron chelators: therapeutic potential and clinical use","volume":"1","author":"Hatcher","year":"2009","journal-title":"Future Med. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2021.111380_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/2040620712450252","article-title":"Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia","volume":"3","author":"Jamuar","year":"2012","journal-title":"Ther. Adv. Hematol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111380_bib47","article-title":"Deferasirox: over a decade of experience in thalassemia","volume":"10","author":"Moukalled","year":"2018","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2021.111380_bib48","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1179\/1607845413Y.0000000121","article-title":"Compliance and satisfaction with deferasirox (Exjade\u00ae) compared with deferoxamine in patients with transfusion-dependent beta-thalassemia","volume":"19","author":"Haghpanah","year":"2014","journal-title":"Hematology"},{"issue":"12","key":"10.1016\/j.biopha.2021.111380_bib49","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/ajh.23844","article-title":"Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with \u03b2-thalassemia major","volume":"89","author":"Casale","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111380_bib50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11657-020-00819-z","article-title":"Impact of iron overload on bone remodeling in thalassemia","volume":"15","author":"Piriyakhuntorn","year":"2020","journal-title":"Arch. Osteoporos."},{"issue":"5","key":"10.1016\/j.biopha.2021.111380_bib51","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1359\/jbmr.040113","article-title":"Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle","volume":"19","author":"Morabito","year":"2004","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.111380_bib52","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1365-2141.2003.04657.x","article-title":"Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia","volume":"123","author":"Voskaridou","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.biopha.2021.111380_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208102","article-title":"Iron chelating properties of Eltrombopag: investigating its role in thalassemia-induced osteoporosis","volume":"13","author":"Punzo","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2021.111380_bib54","doi-asserted-by":"crossref","first-page":"16215","DOI":"10.1038\/s41598-018-34255-4","article-title":"Epigenetic enzymes influenced by oxidative stress and hypoxia mimetic in osteoblasts are differentially expressed in patients with osteoporosis and osteoarthritis","volume":"8","author":"Vrta\u010dnik","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2021.111380_bib55","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10534-005-6666-2","article-title":"Age-associated iron accumulation in bone: implications for postmenopausal osteoporosis and a new target for prevention and treatment by chelation","volume":"19","author":"Liu","year":"2006","journal-title":"Biometals"},{"issue":"1","key":"10.1016\/j.biopha.2021.111380_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3892\/etm.2015.2484","article-title":"Reducing iron accumulation: a potential approach for the prevention and treatment of postmenopausal osteoporosis","volume":"10","author":"Chen","year":"2015","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.biopha.2021.111380_bib57","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/03008207.2018.1439482","article-title":"Therapeutic ionizing radiation induced bone loss: a review of in vivo and in vitro findings","volume":"59","author":"Zhang","year":"2018","journal-title":"Connect. Tissue Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.111380_bib58","doi-asserted-by":"crossref","first-page":"542e","DOI":"10.1097\/PRS.0b013e31829fe548","article-title":"Deferoxamine administration delivers translational optimization of distraction osteogenesis in the irradiated mandible","volume":"132","author":"Felice","year":"2013","journal-title":"Plast. Reconstr. Surg."},{"issue":"5","key":"10.1016\/j.biopha.2021.111380_bib59","doi-asserted-by":"crossref","first-page":"711e","DOI":"10.1097\/PRS.0b013e3182865c57","article-title":"Deferoxamine restores callus size, mineralization, and mechanical strength in fracture healing after radiotherapy","volume":"131","author":"Donneys","year":"2013","journal-title":"Plast. Reconstr. Surg."},{"issue":"1","key":"10.1016\/j.biopha.2021.111380_bib60","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2012.10.014","article-title":"Localized deferoxamine injection augments vascularity and improves bony union in pathologic fracture healing after radiotherapy","volume":"52","author":"Donneys","year":"2013","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.biopha.2021.111380_bib61","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/jbmr.2458","article-title":"Single-limb irradiation induces local and systemic bone loss in a murine model","volume":"30","author":"Wright","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.111380_bib62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jbmr.3289","article-title":"Longitudinal effects of single hindlimb radiation therapy on bone strength and morphology at local and contralateral sites","volume":"33","author":"Oest","year":"2018","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.111380_bib63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00411-015-0623-4","article-title":"Mechanisms of an increased level of serum iron in gamma-irradiated mice","volume":"55","author":"Xie","year":"2016","journal-title":"Radiat. Environ. Biophys."},{"issue":"6","key":"10.1016\/j.biopha.2021.111380_bib64","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1667\/RR3142.1","article-title":"Development of serum iron as a biological dosimeter in mice","volume":"179","author":"Zhang","year":"2013","journal-title":"Radiat. Res."},{"issue":"10","key":"10.1016\/j.biopha.2021.111380_bib65","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1152\/japplphysiol.00997.2015","article-title":"Hindlimb unloading: rodent analog for microgravity","volume":"120","author":"Globus","year":"2016","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.biopha.2021.111380_bib66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bone.2018.06.012","article-title":"Iron overload involved in the enhancement of unloading-induced bone loss by hypomagnetic field","volume":"114","author":"Yang","year":"2018","journal-title":"Bone"},{"issue":"23","key":"10.1016\/j.biopha.2021.111380_bib67","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1182\/blood-2015-12-639112","article-title":"Hepcidin in the diagnosis of iron disorders","volume":"127","author":"Girelli","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biopha.2021.111380_bib68","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/tcmj.tcmj_54_17","article-title":"Alzheimer\u2019s disease and osteoporosis","volume":"29","author":"Chen","year":"2017","journal-title":"Tzu Chi Med. J."},{"issue":"1","key":"10.1016\/j.biopha.2021.111380_bib69","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/03008207.2019.1624734","article-title":"Mechanistic complexities of bone loss in Alzheimer\u2019s disease: a review","volume":"61","author":"Frame","year":"2020","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.biopha.2021.111380_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1100\/2012\/872173","article-title":"Alzheimer\u2019s disease and risk of hip fracture: a meta-analysis study","volume":"2012","author":"Zhao","year":"2012","journal-title":"Sci. World J."},{"issue":"9","key":"10.1016\/j.biopha.2021.111380_bib71","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2021.111380_bib72","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bone.2014.01.010","article-title":"Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function","volume":"61","author":"Li","year":"2014","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.biopha.2021.111380_bib73","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3390\/ijms17101683","article-title":"Amyloid \u03b2 peptide enhances RANKL-induced osteoclast activation through NF-\u03baB, ERK, and calcium oscillation signaling","volume":"17","author":"Li","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2021.111380_bib74","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/jbmr.299","article-title":"APPswe\/A\u03b2 regulation of osteoclast activation and RAGE expression in an age-dependent manner","volume":"26","author":"Cui","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.biopha.2021.111380_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139395","article-title":"Iron chelation inhibits osteoclastic differentiation in vitro and in Tg2576 mouse model of Alzheimer\u2019s disease","volume":"10","author":"Guo","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2021.111380_bib76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1152\/physiol.00061.2014","article-title":"Physiological bone remodeling: systemic regulation and growth factor involvement","volume":"31","author":"Siddiqui","year":"2016","journal-title":"Physiology"},{"issue":"8","key":"10.1016\/j.biopha.2021.111380_bib77","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/cells8080784","article-title":"Mesenchymal stem cell migration and tissue repair","volume":"8","author":"Fu","year":"2019","journal-title":"Cells"},{"issue":"19","key":"10.1016\/j.biopha.2021.111380_bib78","doi-asserted-by":"crossref","first-page":"31626","DOI":"10.18632\/oncotarget.16382","article-title":"Inhibition of iron overload-induced apoptosis and necrosis of bone marrow mesenchymal stem cells by melatonin","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biopha.2021.111380_bib79","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s12011-018-1388-9","article-title":"Iron accumulation leads to bone loss by inducing mesenchymal stem cell apoptosis through the activation of caspase 3","volume":"187","author":"Yuan","year":"2019","journal-title":"Biol. Trace Elem. Res."},{"issue":"5","key":"10.1016\/j.biopha.2021.111380_bib80","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/jre.12136","article-title":"Deferoxamine promotes osteoblastic differentiation in human periodontal ligament cells via the nuclear factor erythroid 2-related factor-mediated antioxidant signaling pathway","volume":"49","author":"Chung","year":"2014","journal-title":"J. Periodontal Res."},{"issue":"9","key":"10.1016\/j.biopha.2021.111380_bib81","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.bbadis.2016.06.003","article-title":"Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin","volume":"1862","author":"Balogh","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.biopha.2021.111380_bib82","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.taap.2010.03.011","article-title":"The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells","volume":"245","author":"Chen","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111380_bib83","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bbrc.2008.03.092","article-title":"Promotion of osteogenesis through beta-catenin signaling by desferrioxamine","volume":"370","author":"Qu","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2021.111380_bib84","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3803\/EnM.2018.33.3.318","article-title":"Regulation of osteoblast metabolism by Wnt signaling","volume":"33","author":"Moorer","year":"2018","journal-title":"Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2021.111380_bib85","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3892\/etm.2014.1823","article-title":"Iron regulates the expression of ferroportin 1 in the cultured hFOB 1.19 osteoblast cell line","volume":"8","author":"Zhao","year":"2014","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.biopha.2021.111380_bib86","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jcb.22559","article-title":"Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts","volume":"110","author":"Genetos","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2021.111380_bib87","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bone.2017.12.021","article-title":"Metabolic properties of the osteoclast","volume":"115","author":"Arnett","year":"2018","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.biopha.2021.111380_bib88","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood.V94.6.2128","article-title":"The cellular labile iron pool and intracellular ferritin in K562 cells","volume":"94","author":"Konijn","year":"1999","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.biopha.2021.111380_bib89","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1093\/nar\/27.21.4223","article-title":"HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation","volume":"27","author":"Bianchi","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2021.111380_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/792639","article-title":"Mitogen-activated protein kinases and reactive oxygen species: how can ros activate MAPK pathways?","volume":"2011","author":"Son","year":"2011","journal-title":"J. Signal Transduct."},{"issue":"10","key":"10.1016\/j.biopha.2021.111380_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.339","article-title":"Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1","volume":"7","author":"Kang","year":"2016","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.biopha.2021.111380_bib92","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jcb.23372","article-title":"Suppression of RANKL-dependent heme oxygenase-1 is required for high mobility group box 1 release and osteoclastogenesis","volume":"113","author":"Sakai","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2021.111380_bib93","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.toxrep.2015.04.005","article-title":"Antioxidant and free radical scavenging activity of iron chelators","volume":"2","author":"Adjimani","year":"2015","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.biopha.2021.111380_bib94","doi-asserted-by":"crossref","DOI":"10.1007\/s12011-020-02508-x","article-title":"Iron overload induces apoptosis and cytoprotective autophagy regulated by ROS generation in Mc3t3-E1 cells","author":"Xu","year":"2021","journal-title":"Biol. Trace Elem. Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.111380_bib95","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12974-019-1430-7","article-title":"Iron accentuated reactive oxygen species release by NADPH oxidase in activated microglia contributes to oxidative stress in vitro","volume":"16","author":"Yauger","year":"2019","journal-title":"J. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.biopha.2021.111380_bib96","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/abbs\/gmaa098","article-title":"ROS signaling cascades: dual regulations for osteoclast and osteoblast","volume":"52","author":"Tao","year":"2020","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"7","key":"10.1016\/j.biopha.2021.111380_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159414","article-title":"Combined iron chelator and antioxidant exerted greater efficacy on cardioprotection than monotherapy in iron-overloaded rats","volume":"11","author":"Wongjaikam","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2021.111380_bib98","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41581-019-0189-5","article-title":"FGF23 at the crossroads of phosphate, iron economy and erythropoiesis","volume":"16","author":"Edmonston","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"15","key":"10.1016\/j.biopha.2021.111380_bib99","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/1873-3468.13494","article-title":"Regulation of fibroblast growth factor 23 (FGF23) in health and disease","volume":"593","author":"B\u00e4r","year":"2019","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.biopha.2021.111380_bib100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s40610-019-0110-9","article-title":"Regulation of fibroblast growth factor 23 by iron, EPO, and HIF","volume":"5","author":"Wheeler","year":"2019","journal-title":"Curr. Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2021.111380_bib101","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11914-020-00574-7","article-title":"Effects of PTH and PTH hypersecretion on bone: a clinical perspective","volume":"18","author":"Rejnmark","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2021.111380_bib102","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jbmr.263","article-title":"Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men","volume":"26","author":"Mirza","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biopha.2021.111380_bib103","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/164_2019_330","article-title":"FGF23 and bone and mineral metabolism","volume":"262","author":"Fukumoto","year":"2020","journal-title":"Handb. Exp. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2021.111380_bib104","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41574-018-0076-3","article-title":"Role of phosphate sensing in bone and mineral metabolism","volume":"14","author":"Chande","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"11","key":"10.1016\/j.biopha.2021.111380_bib105","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1210\/jc.2011-1239","article-title":"Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans","volume":"96","author":"Imel","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"46","key":"10.1016\/j.biopha.2021.111380_bib106","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","article-title":"Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice","volume":"108","author":"Farrow","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2021.111380_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2017.02.005","article-title":"Low serum iron is associated with high serum intact FGF23 in elderly men: the Swedish MrOS study","volume":"98","author":"Lewerin","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2021.111380_bib108","doi-asserted-by":"crossref","first-page":"13601","DOI":"10.1038\/ncomms13601","article-title":"Blood flow controls bone vascular function and osteogenesis","volume":"7","author":"Ramasamy","year":"2016","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2021.111380_bib109","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1530\/JOE-16-0666","article-title":"Mechanical, hormonal and metabolic influences on blood vessels, blood flow and bone","volume":"235","author":"Prisby","year":"2017","journal-title":"J. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111380_bib110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10456-017-9541-1","article-title":"The role of vasculature in bone development, regeneration and proper systemic functioning","volume":"20","author":"Filipowska","year":"2017","journal-title":"Angiogenesis"},{"issue":"3","key":"10.1016\/j.biopha.2021.111380_bib111","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4248\/BR201303001","article-title":"The key role of the blood supply to bone","volume":"1","author":"Marenzana","year":"2013","journal-title":"Bone Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.111380_bib112","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1073\/pnas.0708474105","article-title":"Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration","volume":"105","author":"Wan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.biopha.2021.111380_bib113","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/PRS.0b013e31824422f2","article-title":"Deferoxamine enhances the vascular response of bone regeneration in mandibular distraction osteogenesis","volume":"129","author":"Donneys","year":"2012","journal-title":"Plast. Reconstr. Surg."},{"issue":"5","key":"10.1016\/j.biopha.2021.111380_bib114","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.3892\/mmr.2017.7451","article-title":"Synergistic protection of bone vasculature and bone mass by desferrioxamine in osteoporotic mice","volume":"16","author":"Wang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2021.111380_bib115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bone.2018.10.025","article-title":"SF-deferoxamine, a bone-seeking angiogenic drug, prevents bone loss in estrogen-deficient mice","volume":"120","author":"Guo","year":"2019","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.biopha.2021.111380_bib116","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.1002\/jcp.29799","article-title":"Desferoxamine protects against glucocorticoid-induced osteonecrosis of the femoral head via activating HIF-1\u03b1 expression","volume":"235","author":"Jing","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111380_bib117","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/1535370214553906","article-title":"The effect of deferoxamine on angiogenesis and bone repair in steroid-induced osteonecrosis of rabbit femoral heads","volume":"240","author":"Li","year":"2015","journal-title":"Exp. Biol. Med."},{"issue":"10","key":"10.1016\/j.biopha.2021.111380_bib118","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/jbm.a.35793","article-title":"Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis","volume":"104","author":"Jia","year":"2016","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"1","key":"10.1016\/j.biopha.2021.111380_bib119","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/17474086.2016.1268047","article-title":"Mitochondria and iron: current questions","volume":"10","author":"Paul","year":"2017","journal-title":"Expert. Rev. Hematol."},{"issue":"31","key":"10.1016\/j.biopha.2021.111380_bib120","doi-asserted-by":"crossref","first-page":"12754","DOI":"10.1074\/jbc.R117.787101","article-title":"Iron-sulfur cluster biogenesis and trafficking in mitochondria","volume":"292","author":"Braymer","year":"2017","journal-title":"J. Biol. Chem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221001657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221001657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:31:17Z","timestamp":1760099477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221001657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":120,"alternative-id":["S0753332221001657"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111380","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of iron chelators on osteoporosis and their cellular mechanisms","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111380"}}